Indications for use

For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.

Target Species – Horses

Active Substance(s) – Inactivated EHV1, strain 438/77:RP ≥ 1* Inactivated EHV4, strain 405/76:RP ≥ 1*

Quantity – 10 x 1ml

Format – Suspension for injection